| Literature DB >> 18292944 |
M Kamrul Hasan1, Tomoko Yaguchi, Jun Itadani Harada, Takashi Hirano, Renu Wadhwa, Sunil C Kaul.
Abstract
We initially cloned CARF (collaborator of ARF), as a novel ARF-binding protein by a yeast interaction screen. It also interacts with p53 directly leading to ARF-independent enhancement of p53 function and in turn undergoes a negative feedback regulation. Herein we report that i) CARF interacts with HDM2 and undergoes degradation by an HDM2-dependent proteasome pathway, and ii) it acts as a transcriptional repressor of HDM2. By overexpression and silencing studies, we demonstrated that CARF exerts a vital control on the p53-HDM2-p21WAF1 pathway that is frequently altered in cancer cells.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18292944
Source DB: PubMed Journal: Int J Oncol ISSN: 1019-6439 Impact factor: 5.650